Please login to the form below

Not currently logged in

EUSA Pharma adds William Crouse to board of directors

Comes as firm hopes to become global leader in biotechnology

EUSA Pharma has appointed William Crouse to its board of directors.

Crouse joins with 50 years of experience in the life sciences industry with his most recent role being general partner at Healthcare Venture, one of the world's largest venture capital firms specialising in biotechnology.

Prior to this, in his many roles over 30 years he has worked in the diagnostics industry, international operations, strategic planning, acquisitions, new product development and sales and marketing.

He said: “It's an honour to join EUSA and to help this ambitious company become a major force in the speciality field.

“Having worked with many of the EUSA team previously, I am confident the company has the capabilities and infrastructure in place to rapidly become a leading player in the sector.”

Bryan Morton, executive chairman at EUSA Pharma, said: “We have great ambitions for EUSA, and plan to grow our existing profitable business through acquisition and in-licensing.

“Bill's extensive experience and strategic insight will be a huge asset as we transform our business into a leading transatlantic speciality commercialization company.”

9th September 2015

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...
figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...